🇺🇸 FDA
Patent

US 8507653

Factor IX moiety-polymer conjugates having a releasable linkage

granted A61KA61K47/60A61P

Quick answer

US patent 8507653 (Factor IX moiety-polymer conjugates having a releasable linkage) held by Nektar Therapeutics expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K47/60, A61P, A61P7/00, A61P7/04